Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

123
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
123
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

726
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
726
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

142
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
142
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

665
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
665
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

612
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
612
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

176
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral contraceptive usage among healthcare workers and its impact on COVID-19 booster vaccination immunogenicity.

NPJ vaccines·2026
Same author

Impact of serum potassium levels on success of electrical cardioversion in atrial fibrillation.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Cardiac dysfunction after acute ischaemic stroke: Long-term outcomes from the SICFAIL cohort.

International journal of cardiology. Heart & vasculature·2026
Same author

A novel signal distribution-based approach to characterize atrial cardiomyopathy.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Artificial intelligence as the missing integrator in heart failure care - from remote monitoring to personalized therapy.

Cardiology journal·2026
Same author

Myocardial work analysis during semi-supine stress echocardiography: exercise response patterns in heart failure patients and controls.

European heart journal. Imaging methods and practice·2026

Related Experiment Video

Updated: Dec 7, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K

[Pharmacotherapy in HFrEF].

Gülmisal Güder, Stefan Frantz

    Deutsche Medizinische Wochenschrift (1946)
    |September 24, 2020
    PubMed
    Summary
    This summary is machine-generated.

    New drug developments offer hope for optimizing heart failure therapy. This review updates recent pharmacotherapeutic options for managing complex chronic heart failure cases.

    More Related Videos

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
    10:05

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

    Published on: July 7, 2016

    8.7K
    Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
    03:42

    Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

    Published on: March 29, 2024

    1.9K

    Related Experiment Videos

    Last Updated: Dec 7, 2025

    A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
    07:09

    A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

    Published on: February 18, 2022

    2.2K
    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
    10:05

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

    Published on: July 7, 2016

    8.7K
    Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
    03:42

    Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

    Published on: March 29, 2024

    1.9K

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • The 2016 European Society guidelines for heart failure require updates due to new evidence.
    • Optimizing heart failure therapy is complex due to numerous treatment options and comorbidities.

    Purpose of the Study:

    • To provide an update on recent pharmacotherapeutic options for chronic heart failure.
    • To offer practical support for clinicians managing heart failure patients.

    Main Methods:

    • Review of recent studies and clinical evidence.
    • Analysis of new drug developments and therapeutic strategies.

    Main Results:

    • Emerging drug therapies show promise in improving heart failure prognosis.
    • Integration of new pharmacotherapies can help manage complex cases.

    Conclusions:

    • Recent advancements offer improved control over progressive heart disease.
    • Updated pharmacotherapeutic strategies are crucial for effective chronic heart failure management.